Acadia Healthcare Company, Inc. $ACHC Shares Acquired by Russell Investments Group Ltd.

Key Points

• Russell Investments Group Ltd. significantly increased its stake in Acadia Healthcare by 261.7%, acquiring an additional 48,199 shares to hold a total of 66,620 shares, valued at approximately $2 million.
• Acadia Healthcare reported $0.83 earnings per share for the last quarter, exceeding estimates of $0.71, alongside a revenue of $869.23 million.
• Recent analyst reports have led to mixed ratings for Acadia Healthcare, with price targets ranging from $22.00 to $40.77, indicating a general consensus of 'Moderate Buy'.

Russell Investments Group Ltd. grew its position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 261.7% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 66,620 shares of the company's stock after buying an additional 48,199 shares during the period. Russell Investments Group Ltd. owned 0.07% of Acadia Healthcare worth $2,020,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in ACHC. UMB Bank n.a. grew its position in Acadia Healthcare by 149.5% in the first quarter. UMB Bank n.a. now owns 1,260 shares of the company's stock worth $38,000 after acquiring an additional 755 shares during the period. State of Wyoming acquired a new position in shares of Acadia Healthcare in the 4th quarter valued at $56,000. Covestor Ltd grew its holdings in shares of Acadia Healthcare by 56.0% during the 1st quarter. Covestor Ltd now owns 2,262 shares of the company's stock worth $69,000 after purchasing an additional 812 shares during the period. Aquatic Capital Management LLC acquired a new stake in shares of Acadia Healthcare during the 4th quarter worth about $97,000. Finally, GAMMA Investing LLC raised its holdings in Acadia Healthcare by 143.8% in the 1st quarter. GAMMA Investing LLC now owns 5,812 shares of the company's stock valued at $176,000 after buying an additional 3,428 shares during the period.

Analyst Upgrades and Downgrades

A number of research firms have commented on ACHC. Mizuho decreased their price target on Acadia Healthcare from $32.00 to $22.00 and set a "neutral" rating on the stock in a research note on Wednesday, August 13th. Wall Street Zen upgraded Acadia Healthcare from a "sell" rating to a "hold" rating in a research note on Sunday, August 3rd. Cowen restated a "buy" rating on shares of Acadia Healthcare in a research note on Thursday, August 7th. Stephens upgraded shares of Acadia Healthcare to a "hold" rating in a research note on Monday, June 2nd. Finally, Barclays dropped their price objective on shares of Acadia Healthcare from $28.00 to $20.00 and set an "equal weight" rating on the stock in a research report on Thursday, August 7th. Nine equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat.com, Acadia Healthcare currently has a consensus rating of "Moderate Buy" and a consensus target price of $40.77.

Acadia Healthcare Stock Up 1.5%

NASDAQ:ACHC traded up $0.34 during midday trading on Monday, hitting $22.96. 2,743,238 shares of the company were exchanged, compared to its average volume of 2,671,607. Acadia Healthcare Company, Inc. has a fifty-two week low of $17.13 and a fifty-two week high of $82.40. The company has a market capitalization of $2.12 billion, a PE ratio of 15.21, a price-to-earnings-growth ratio of 4.52 and a beta of 0.89. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.73. The company has a fifty day simple moving average of $22.06 and a 200 day simple moving average of $25.19.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last released its quarterly earnings data on Tuesday, August 5th. The company reported $0.83 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.71 by $0.12. Acadia Healthcare had a net margin of 4.31% and a return on equity of 8.34%. The company had revenue of $869.23 million during the quarter, compared to the consensus estimate of $839.59 million. During the same quarter in the prior year, the firm posted $0.91 earnings per share. Acadia Healthcare's revenue for the quarter was up 9.2% on a year-over-year basis. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS. As a group, equities analysts anticipate that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current fiscal year.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.